Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3006

Actual shortage: 229 (8%)
Anticipated shortage: 21 (1%)
Avoided shortage: 9 (0%)
Resolved: 2747 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

27 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179447
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-13 2023-04-21 181107
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-09 2023-03-02 184086
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-09 2023-02-23 184100
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-16 2023-05-12 185019
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185967
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185973
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185976
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185982
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185985
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-09 2023-04-06 186575
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-16 2023-04-06 187238
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-06 2023-04-21 188973
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-14 2024-02-02 189647
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-29 190874
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-06-09 191880
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-05-12 191898

Showing 2881 to 2900 of 3006

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 356